Correlation Between Metacrine and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Metacrine and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and Ikena Oncology, you can compare the effects of market volatilities on Metacrine and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and Ikena Oncology.
Diversification Opportunities for Metacrine and Ikena Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Metacrine and Ikena is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Metacrine i.e., Metacrine and Ikena Oncology go up and down completely randomly.
Pair Corralation between Metacrine and Ikena Oncology
If you would invest (100.00) in Metacrine on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Metacrine or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Metacrine vs. Ikena Oncology
Performance |
| Timeline |
| Metacrine |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Ikena Oncology |
Metacrine and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Metacrine and Ikena Oncology
The main advantage of trading using opposite Metacrine and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |